Three independent discounted-cash-flow-style models value Astrana Health Inc. Common Stock every trading day. 2 of 3 currently price ASTH above its market price.
| Free Cash Flow model | $332.63 |
| Excess Profit model | $85.03 |
| Residual Earnings model | $-0.03 |
| Dividend Discount model | — |
| Piotroski F-Score | 4 / 9 |
| Return on invested capital | +3.4% |
| Net debt / EBITDA | 7.8× |
| Gross margin | +100.0% |
| Revenue CAGR | +56.4% |
| Cash conversion | 4.8× |
| Dividend yield | — |
| Buyback yield | -3.1% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open ASTH in StockKitty